<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20261017071464N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-10-25</date_registration>
      <primary_sponsor>Hamedan University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the Effectiveness of Dignity Therapy Versus Usual Supportive Psychological Care in Reducing Demoralization and Improving Quality of Life in Patients with Limb Amputation: A Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Effectiveness of Dignity Therapy Versus Usual Supportive Psychological Care in Reducing Demoralization and Improving Quality of Life in Patients with Limb Amputation: A Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-10-23</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>60</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/94188</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Randomization description: The study participants will be randomly assigned to two groups, A and B, using block randomization with a block size of 4. Randomization will be performed using an envelope containing four slips of paper, two labeled A and two labeled B. For each patient, one slip will be drawn to determine group allocation. The selected slip will not be returned to the envelope until all four slips have been drawn. After the allocation of the first four patients, all four slips will be returned to the envelope, and the same procedure will be repeated for each subsequent block of four patients until the required sample size is reached. Patients in Group A will receive dignity therapy, while patients in Group B will receive supportive psychological care.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Patients with limb amputation.</hc_freetext>
      <i_freetext>Intervention 1: Intervention Group (Dignity Therapy): Dignity therapy is a brief psychotherapeutic intervention designed to enhance a sense of worth, meaning, and purpose in life and to reduce psychosocial and existential distress. The intervention will consist of three sessions. In the first session, a trained therapist will explain the goals of the therapy and the interview process to the patient and introduce the dignity therapy questions. In the second session, approximately 24–48 hours later, a semi-structured interview lasting approximately 60 minutes will be conducted, focusing on the patient’s life history, meaningful memories, accomplishments, values, hopes, and messages they wish to leave for their loved ones. The interview will be audio-recorded, transcribed, and compiled into a written document known as a generativity document. In the final session, the document will be presented to the patient for review and approval. After incorporating any requested revisions, the finalized document will be provided to the patient, who may share it with family members and loved ones if desired. At the end of the intervention, the study questionnaires will be administered again. Intervention 2: Control Group: Patients assigned to Group B, who will receive usual supportive psychological care, will have access to the full range of supportive services available to all study participants, including specialist physicians and nurses (i.e., professionals trained in providing supportive psychological care), social workers, and psychologists or psychiatrists. This will ensure that the necessary resources are available to address the physical, existential, and psychosocial needs of patients and their families. Healthcare professionals providing these services will address patients’ current concerns and problems but will not focus on enhancing their sense of legacy. In other words, a structured intervention comparable to dignity therapy will not be provided to patients randomly assigned to this group. Patients will be asked to complete the study questionnaires immediately after allocation to Group B and again after receiving usual supportive psychological care.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no further information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Sina Ghasemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Sciences, Shahid Fahmideh Boulevard, Pajouhesh Square, Hamadan, Iran</address>
        <city>hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۵۱۷۸۳۸۷۳۶</zip>
        <telephone>+98 901 669 0780</telephone>
        <email>sinaghasemi19980@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Sina Ghasemi</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Hamadan University of Medical Sciences, Shahid Fahmideh Boulevard, Pajouhesh Square, Hamadan, Iran</address>
        <city>hamadan</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>۶۵۱۷۸۳۸۷۳۶</zip>
        <telephone>+98 901 669 0780</telephone>
        <email>sinaghasemi19980@gmail.com</email>
        <affiliation>Hamedan University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients who underwent amputation during the study period
Ability to read and speak Persian
Obtaining Written Informed Consent</inclusion_criteria>
      <agemin>18 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Individuals with cognitive disorders, such as dementia and delirium.
Patients who were too ill to meet the study requirements
Severe neurological disorder (the severity of the illness and neurological disorder will be assessed based on the physician’s judgment).</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Y83.5</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Amputation of limb(s)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention Group (Dignity Therapy): Dignity therapy is a brief psychotherapeutic intervention designed to enhance a sense of worth, meaning, and purpose in life and to reduce psychosocial and existential distress. The intervention will consist of three sessions. In the first session, a trained therapist will explain the goals of the therapy and the interview process to the patient and introduce the dignity therapy questions. In the second session, approximately 24–48 hours later, a semi-structured interview lasting approximately 60 minutes will be conducted, focusing on the patient’s life history, meaningful memories, accomplishments, values, hopes, and messages they wish to leave for their loved ones. The interview will be audio-recorded, transcribed, and compiled into a written document known as a generativity document. In the final session, the document will be presented to the patient for review and approval. After incorporating any requested revisions, the finalized document will be provided to the patient, who may share it with family members and loved ones if desired. At the end of the intervention, the study questionnaires will be administered again.</i_keyword>
      <i_keyword>Control Group: Patients assigned to Group B, who will receive usual supportive psychological care, will have access to the full range of supportive services available to all study participants, including specialist physicians and nurses (i.e., professionals trained in providing supportive psychological care), social workers, and psychologists or psychiatrists. This will ensure that the necessary resources are available to address the physical, existential, and psychosocial needs of patients and their families. Healthcare professionals providing these services will address patients’ current concerns and problems but will not focus on enhancing their sense of legacy. In other words, a structured intervention comparable to dignity therapy will not be provided to patients randomly assigned to this group. Patients will be asked to complete the study questionnaires immediately after allocation to Group B and again after receiving usual supportive psychological care.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Demoralization (Existential Distress). Timepoint: Before the intervention and after the completion of the intervention. Method of measurement: Use of questionnaire scores.</prim_outcome>
      <prim_outcome>Quality of Life. Timepoint: Before the intervention and after the completion of the intervention. Method of measurement: Use of questionnaire scores.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Hamedan University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-10-19</approval_date>
        <contact_name>Research Ethics Committee of Hamadan University of Medical Sciences</contact_name>
        <contact_address>Hamadan University of Medical Sciences, Shahid Fahmideh Boulevard, Pajouhesh Square, Hamadan, Iran hamadan Hamadan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
